Targeting LIPA Independent of Its Lipase Activity Is a Therapeutic Strategy in Solid Tumors via Induction of Endoplasmic Reticulum Stress

Investigators defined lysosomal acid lipase A (LIPA) as a viable molecular target in TNBC and identified a stereospecific small molecule that binds LIPA.